- Enrolling by invitationPHASE3
Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies
This study offers ongoing access to a medicine called berotralstat for people with Hereditary Angioedema (HAE) who have already taken part in previous berotralstat studies. It aims to check the long-term safety of the treatment.
For: Hereditary Angioedema · HAECanada · Czechia · France - Active not recruitingPHASE3
Berotralstat Treatment in Children With Hereditary Angioedema
This study looks at a medicine called berotralstat for children aged 2 to 11 with hereditary angioedema (HAE). Researchers want to find the right dose for children based on their weight, check if it's safe, and see how well it prevents HAE attacks.
For: Hereditary Angioedema · PediatricAustria · Canada · France